Ligand validation:9FRO

NDG: 2-acetamido-2-deoxy-alpha-D-glucopyranose

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
9FRO_NDG_D_101	60%	54%	0.112	0.895	0.72	1.06	1	1	0	0	100%	0.72
9FRO_NDG_B_101	57%	56%	0.114	0.888	0.64	1.04	-	1	0	0	100%	0.82
9FRO_NDG_C_101	49%	56%	0.124	0.871	0.66	1.03	-	1	0	0	100%	0.75
9FRO_NDG_A_101	4%	55%	0.318	0.71	0.64	1.1	-	1	0	0	100%	0.42
8R3D_NDG_E_101	96%	54%	0.057	0.963	0.78	0.98	1	1	0	0	100%	1
8R3C_NDG_G_101	93%	52%	0.061	0.955	0.64	1.22	-	2	0	0	100%	1
8R3B_NDG_A_103	91%	53%	0.064	0.948	0.71	1.09	1	1	0	0	100%	1
4GVF_NDG_A_401	97%	29%	0.06	0.978	1.66	1.18	4	2	0	0	100%	0.7
2UVO_NDG_B_1176	97%	71%	0.059	0.975	0.42	0.68	-	-	0	0	100%	1
2ZUV_NDG_A_2001	97%	50%	0.066	0.978	0.54	1.38	-	2	0	0	100%	1
5A3L_NDG_C_1237	96%	58%	0.066	0.974	0.44	1.15	-	2	0	0	100%	0.5

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.